Prevalence and predictors of neoadjuvant therapy for stage IIIA non-small cell lung cancer in the national cancer database: Importance of socioeconomic status and treating institution

David J. Sher, Michael J. Liptay, Mary Jo Fidler

Research output: Contribution to journalArticlepeer-review

15 Scopus citations

Fingerprint

Dive into the research topics of 'Prevalence and predictors of neoadjuvant therapy for stage IIIA non-small cell lung cancer in the national cancer database: Importance of socioeconomic status and treating institution'. Together they form a unique fingerprint.

Medicine & Life Sciences

Physics & Astronomy